You are here: Industry Insights > Baxter

News List

Baxter Indonesia launches My Kidney Journey portal to support patients with Chronic Kidney Disease prnasia
November 16, 2021
Baxter Asia Pacific (Baxter), a global leader in dialysis care, announced today the launch of My Kidney Journey (www.infoginjal.com), a comprehensive online portal to support patients living with Chronic Kidney Disease (CKD) in Indonesia.
Baxter Biopharma Solutions Enters Sterile Manufacturing Agreement for Novavax’ COVID-19 Vaccine contractpharma
March 10, 2021
New highly scalable line of bioreactors designed to ensure seamless scalability from early process development to commercial manufacturing.
Baxter, Novavax Ink Sterile Manufacturing Agreement contractpharma
January 12, 2021
CMO Baxter will help increase commercial production and promote access to Novavax' Covid-19 vax in UK and European markets.
Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations contractpharma
November 25, 2020
Baxter International Inc. has announced a $50 million expansion of its sterile fill/finish manufacturing facilities located in Bloomington, IN.
Baxter, Oasmia Ink Apealea Commercial Mfg. Pact pharmatimes
December 10, 2018
Oasmia Pharmaceutical AB signed a new five-year contract with Baxter BioPharma Solutions for global commercial manufacturing of Apealea.
Baxter partners up with Mayo Clinic for new "centre of exellence" in renal care pharmafile
November 20, 2018
American pharma firm Baxter has announced a new partnership with the Mayo Clinic in a bid to establish a “renal care centre of excellence” in the US.
FDA clears Baxter’s prepackaged synthetic bone filler graft fiercebiotech
September 10, 2018
Baxter expects the bone filler to be used in surgeries in the pelvis, extremities and spine, to help repair small bone defects and complex geometries.
Baxter Announces FDA Clearance of Actifuse Flow americanpharmaceuticalreview
September 07, 2018
Baxter announced U.S. Food and Drug Administration (FDA) clearance of Actifuse Flow Bone Graft Substitute for use in a variety of ...
Baxter Announces FDA Clearance of Actifuse Flow americanpharmaceuticalreview
September 07, 2018
Baxter announced U.S. Food and Drug Administration (FDA) clearance of Actifuse Flow Bone Graft Substitute for use in a variety of orthopedic surgical procedures.
FDA nails Baxter with warning letter for plant picked up in Claris buyout fiercepharma
July 27, 2018
At exactly the same time that Baxter International was closing its $625 million deal for Claris Injectables last year, FDA inspectors were taking a hard look at one of the three plants Baxter had acquired. Turns out they were not very impressed with its m